Dark Forest Capital Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-130
Closed -$7.51K 1197
2022
Q4
$7.51K Buy
130
+126
+3,150% +$7.78K ﹤0.01% 798
2022
Q3
$0 Buy
+4
New +$569 ﹤0.01% 1164
2022
Q1
Sell
-187
Closed -$123K 1322
2021
Q4
$123K Buy
187
+141
+307% +$108K 0.05% 311
2021
Q3
$39K Buy
+46
New +$46.7K 0.01% 628

Other funds holding CDLX

Dark Forest Capital Management's CDLX Position: Q1 2023 in Review

Dark Forest Capital Management sold out of Cardlytics (CDLX) in Q1 2023, closing a stake of 130 shares — an estimated $7.51K sold.

Dark Forest Capital Management first reported a position in CDLX in Q3 2021 and held it in 4 quarters. The position peaked at $123K in Q4 2021. 103 funds tracked by Wall St. Rank hold CDLX as of Q1 2023.

  • Dark Forest Capital Management reported no remaining Cardlytics position as of Q1 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 130 Cardlytics shares in Q1 2023, an estimated $7.51K.
  • Dark Forest Capital Management first reported a position in Cardlytics in Q3 2021 and held it in 4 quarters.
  • Dark Forest Capital Management's Cardlytics position peaked at $123K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Cardlytics as of Q1 2023.

Based on Dark Forest Capital Management's 13F filing for Q1 2023, filed 12 May 2023.